Over 10 years ago, we decided to take on the challenge of developing a new tool that can help clinicians decide if an infection is bacterial or viral, and founded a biotech company, MeMed.
Read more on Longitude Prize here.
Over 10 years ago, we decided to take on the challenge of developing a new tool that can help clinicians decide if an infection is bacterial or viral, and founded a biotech company, MeMed.
Read more on Longitude Prize here.
![[NanoLock in PR Newswire] NanoLock Combats Cyber Chaos with Commercial Availability of Device-Level Industrial Cybersecurity Suite](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
